Title:
臨床的に認められた抗ウイルス剤を用いるSARSコロナウイルス感染の阻害
Document Type and Number:
Japanese Patent JP2006527268
Kind Code:
A
Abstract:
The invention relates to methods for treating or inhibiting SARS-CoV infection involving the administration of an interferon, particularly IFN alpha-n1, IFN alpha-n3, human leukocyte IFN alpha or IFN beta-1b.
Inventors:
Tan, Emily Lichan
Stanton, Lawrence W..
Stanton, Lawrence W..
Application Number:
JP2006517062A
Publication Date:
November 30, 2006
Filing Date:
June 09, 2004
Export Citation:
Assignee:
Genome Institute of Singapore
International Classes:
A61K38/21; A61K31/4196; A61K31/7056; A61K45/00; A61P11/00; A61P31/12
Attorney, Agent or Firm:
Yuichi Yamada
Masakazu Noda
Kimoto
Masakazu Noda
Kimoto